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The glycocalyx of human cells differs from that of many other mammals by the lack
of the sialic acid N-glycolylneuraminic acid (Neu5Gc) and increased abundance of
its precursor N-acetylneuraminic acid (Neu5Ac). Most humans also have circulating
antibodies specifically targeting the non-human sialic acid Neu5Gc. Recently, several
additional mammalian species have been found to also lack Neu5Gc. In all cases,
loss-of-function mutations in the gene encoding the sialic acid-modifying enzyme CMAH
are responsible for the drastic change in these species. Unlike other glycan antigens,
Neu5Gc apparently cannot be produced by microbes, raising the question about the
origin of these antibodies in humans. Dietary exposure and presentation on bacteria
coating themselves with Neu5Gc from the diet are distinct possibilities. However, the
majority of the non-human species that lack Neu5Gc do not consume diets rich in
Neu5Gc, making it unlikely that they will have been immunized against this sialic acid. A
notable exception are mustelids (ferrets, martens and their relatives) known for preying on
various small mammal species rich in Neu5Gc. No studies exist on levels of anti-Neu5Gc
antibodies in non-human species. Evolutionary scenarios for the repeated, independent
fixation of CMAH loss-of-function mutations at various time points in the past include
strong selection by parasites, especially enveloped viruses, stochastic effects of genetic
drift, and directional selection via female immunity to paternal Neu5Gc. Convergent
evolution of losses of the vertebrate-specific self-glycan Neu5Gc are puzzling and may
represent a prominent way in which glycans become agents of evolutionary change in
their own right. Such change may include the reconfiguration of innate immune lectins
that use self-sialic acids as recognition patterns.
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INTRODUCTION
The glycocalyx of all vertebrate cells is decorated with abundant terminal sialic acids. These acidic
nine-carbon backbone sugars cap the ends of tens to hundreds of millions of glycan chains per cell.
In mammalian species and other vertebrates, the sialic acids N-acetylneuraminic acid (Neu5Ac)
and its derivative N-glycolylneuraminic acid (Neu5Gc) are the two most common forms, each a
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family of molecules with various modifications of the canonical,
9-carbon monosaccharide (1). Until recently, humans were the
only mammalian species known to lack the sialic acid Neu5Gc,
as our lineage fixed the loss-of-function mutation affecting the
single copy CMAH gene that encodes the sialic acid-modifying
enzyme CMAH over 2 million years ago in the lineage leading
to H. sapiens (2, 3). More recently, several other species of
mammals have been documented to also lack Neu5Gc due to
ancientmutations fixed over 30million years ago in these lineages
(4–6). The loss of function of the CMAH enzyme prevents the
modification of the precursor monosaccharide to the derived
sialic acid Neu5Gc (in their respective sugar-nucleotide form,
CMP-Neu5Ac and CMP-Neu5Gc). As illustrated in Figure 1, the
lack of this enzymatic function can lead to drastic changes in
the molecular composition of the glycocalyx of cells throughout
the body. Recent evidence has shown that humans are not
FIGURE 1 | Modification of CMP-Neu5Ac to CMP-Neu5Gc. (A) The enzyme CMAH, encoded by a single gene in all mammals, catalyzes the derivatization of Neu5Ac
to Neu5Gc in the form of their sugar nucleotides, cytidine monophosphate (CMP). (B) Due to the large number of sialic acids terminating many of the glycan chains on
the glycocalyces of most cells, the loss of function of the CMAH gene leads to a drastic change in the molecular identity or “flavor” of the glycocalyx, as indicated by a
small fraction of a red blood cell membrane, redrawn and modified from Viitala and Järnefelt (7). (C) Micrographs showing green immunofluorescent staining of
Neu5Gc on chimpanzee but not human sperm cells stained with affinity purified chicken anti-Neu5Gc IgY antibody and fluorescent secondary, controls include
sialidase treated or anti-IgY secondary antibody alone, nuclei stained by DAPI (blue) reprinted from Ghaderi et al. (8) with permission.
alone in this loss, instead several other species of mammals
have independently fixed different loss-of-function mutations
of their Cmah gene at various time depths during evolution,
leading to loss of Neu5Gc in entire lineages or just individual
species (6). These losses have occurred through exon deletion,
premature stop codons, or frameshift mutations in the gene
encoding the CMAH enzyme (4–6). The picture emerging is
that of a phylogeny of mammals punctuated with taxa that
have lost the capacity to synthesize Neu5Gc (Figure 2). These
taxa include New World primates (>100 species of South and
Central American primates known as Platyrrhynes), Mustelidae
(57 species of small carnivores including ferrets, martens and
weasels), pinnipeds (33 species comprising seals, sea-lions and
walruses), Procyonidae (∼15 species including racoons, ring-
tails and coatis,) hedgehogs (17 species), bats from at least two
different lineages, spermwhale (a single species), and white-tailed
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FIGURE 2 | Parallel evolution and loss of an innate self-signal. Humans cannot synthesize Neu5Gc, because human CMAH was inactivated over two million years
ago (red). The inactivating mutation apparently fixed rapidly after originating, which suggests that the loss could have been adaptive—driven by pathogen avoidance,
reproductive conflict, or a combination of the two. Independent losses of Cmah function have recently been found in New World Primates, Mustelids and several other
groups. Figure modified from Springer and Gagneux (9). In some lineages, such as bats and toothed whales, only certain species lost the capacity to make Neu5Gc
(indicated by lines that are both blue and red).
deer (a single species) (4–6). For most of these groups, only a few
representative taxa and a few individuals have been studied at the
genomic level, and so there is the possibility that the Cmah gene
remained intact or polymorphic in some of the taxa.
An obvious prediction is that additional taxa with inactivated
Cmah genes will be discovered as additional complete genome
sequences are obtained. These cases of convergent molecular
evolution result in an overall reconfiguration of the outermost
layer of the glycocalyx, now lacking Neu5Gc and carrying an
excess of Neu5Ac, given that human and non-human cells
retain comparable levels of sialic acid (10) (see Figure 1B
for red blood cells and Figure 1C for sperm cells). Among
the many functions of the glycocalyx, molecular identity is
paramount (11–13). The molecular patterns, as defined by
composition and structure of the glycocalyx have evolved into
self-associated molecular patterns (SAMPs) (14), that contribute
to efficient surveillance by innate immune receptors including
complement factor H and Siglecs, which can inhibit immune
response upon engagement with SAMPs (14, 15). Losing
Neu5Gc would dramatically alter self-recognition. This would
have required evolving altered receptor specificities, affinities,
and knock-on effects in signaling pathways due to altered
engagement of innate receptors. The biochemical impact of
the altered sialome on the human glycocalyx could have had
many other effects, including changes in inflammation and
metabolism (16, 17).
Another potential consequence are autoreactive antibodies
produced against the lost sialic acid. Indeed, despite the
absence of endogenous Neu5Gc, experimental studies in
humans and in Cmah(−/−) mice have revealed that dietary
Neu5Gc, in both free and glycoconjugate-bound forms, can
become incorporated into tissues in trace amounts. This
incorporation occurs especially in tissues with rapid growth
and/or turnover rates, including epithelia, endothelia, fetal
tissues, and carcinomas (18–20). It has also been established
that all humans have various levels of circulating antibodies
specific for glycans carrying this foreign molecule, essentially
making Neu5Gc a “xeno-autoantigen,” which can cause
“xenosialitis,” an inflammation due to reaction against a
xeno-sialic acid that is now part of “self ” molecules (21–24).
Surprisingly, even humans on diets extremely rich in Neu5Gc
do not appear to accumulate beyond trace levels of this
dietary xenoglycan.
How ingested Neu5Gc becomes incorporated into the human
body remains incompletely understood. There is evidence that
Neu5Gc is converted to GalNGc and can then be incorporated
into the glycosaminoglycan chondroitin sulfate, an important
component of extra-cellular matrices and skeletal bone (25).
This incorporation has recently allowed the identification of
GalNGc in bones and in fossilized bones as old as 3 million
years, opening the possibility to study ancient glycomes of
extinct hominins (26). There is much ongoing research to
understand the potential effects of incorporation of dietary xeno-
sialic acid and targeting antibodies against xeno-sialic acid,
xenosialitis in the context of cancer and autoimmunity and
even unexplained infertility, where chronic immune reactions
to incorporated xenoglycans could contribute to xenosialitis
(22–24, 27–29). Aside from humans, natural levels of anti-
Neu5Gc antibodies in other species lacking Neu5Gc have not
been studied to date. However, anti-Neu5Gc antibodies have
been seen in chickens, where antibodies can be efficiently
generated upon immunization (18) and are the basis of
immune assays for the detection of Neu5Gc in human
samples (30).
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NATURAL IMMUNIZATION
AGAINST NEU5GC-GLYCANS
There are four main differences between immunization against
Neu5Gc and other xenoglycans, such as the disaccharide alpha-
Gal, or alloglycans such as ABO oligosaccharide antigens. First,
in the case of other xenoglycans, immunization against the
missing, terminal “self ”-glycan is thought to be caused by
encounters with microbial glycans with the same structure (31,
32). Considering that the synthesis of endogenous Neu5Gc
has never been documented for any microbe, it would appear
unlikely that this microbial priming method occurs for Neu5Gc
(33, 34). Despite the apparent lack of Neu5Gc synthetic
capacity in microbes, however, at least one microbe, Non-
typeable Haemophilus influenzae (NTHi), can scavenge dietary
Neu5Gc and incorporate it into its own glycolipids. There is
evidence that young human infants are “xeno-autoimmunized”
against Neu5Gc by early H. influenzae infection and this
method has also been utilized for experimental immunization
of Cmah(−/−) mice in the laboratory (35). Immunization thus
seems to depend on diets rich in Neu5Gc from red meats
or certain marine sources (fish eggs or echinoderms (27, 36).
Secondly, unlike other xenoglycans, it is important to stress
that the monosaccharide Neu5Gc itself is immunogenic, none
of the constituent monosaccharides of alpha-Gal (galactose) or
ABO antigens (fucose, galactose, N-Acetylgalactosamine, and
N-Acetylglucosamine) are foreign to individuals lacking these
structures and once ingested, they are incorporated as non-
antigenic glycans or metabolized (37). The antigenicity of other
xenoglycans, is largely determined by glycosidic linkages, rather
than by the nature of the monosaccharide: galactose-alpha-1,3-
galactose for alpha-Gal; fucose-alpha-1,2-galactose for the H
antigen; H antigen with N-Acetylgalactosamine for A antigen;
or H antigen with alpha-1,3-galactose for B antigen. Thirdly,
unlike the other immunogenic glycans, Neu5Gc can be part of
numerous different antigens depending on the identity of the
sialoglycoconjugate they occur on. Finally, sialic acids are one to
several orders ofmagnitudemore abundant than either alpha-Gal
or ABO glycans (38, 39). These three differences: dietary origin,
antigenicity of the monomer itself, and ubiquity/abundance on
the cell surface make Neu5Gc a unique antigen, whose loss may
lead to wide-ranging physiological effects (37, 38).
While humans have many dietary sources for Neu5Gc, among
the New World primates, there are very few species that eat
vertebrate meat. Capuchin monkeys (genera Cebus and Sapajou)
are known to prey on young coati (40), relatives of racoons
belonging to the family of Procyonidae, and on lizards or birds,
but these prey species all lack endogenous Neu5Gc (5, 41). It is
thus very unlikely that these NewWorld primates are immunized
against Neu5Gc in the wild, but captive capuchin monkeys may
be exposed to Neu5Gc through monkey chow containing red
meat (Primate Info Net, University of Wisconsin). Hedgehogs
and other insectivores, consume mostly insect prey that lack
sialic acids and thus can be safely expected not to be naturally
immunized against Neu5Gc (6). The same can be said for the
different bat species that lack Neu5Gc, as these all feed on insects,
fruit, or nectar (42). Pinnipeds (seals, sea-lions and walruses)
are all strict carnivores and some of their prey include fish and
marine invertebrates that could contain Neu5Gc (43). Studies of
pinniped immune responses to sialic acids are urgently needed.
The one species of whale also lacking Neu5Gc is the sperm whale
(Physeter catodon) (6), whose diet consists mostly of giant squid
and other cephalopods (squid and octopus) with occasional fish
(44). Again, such a diet is unlikely to expose spermwhales to large
amounts of Neu5Gc (45), leading to the prediction that they will
not have circulating antibodies against the xenoglycan. Mustelids
are the one group of species for which it can be assumed that
dietary exposure and immunization occurs, as they are all known
to feed on a variety of small mammals and vertebrates (46).
EVOLUTIONARY MECHANISMS FOR THE
FIXATION OF LOSS-OF-FUNCTION
MUTATION
The loss-of-function mutations of the Cmah gene are by
definition recessive, as one copy of the functional gene suffices
to generate a Neu5Gc positive phenotype in a diploid organism.
Balancing Selection Maintaining
Polymorphisms
Some animals, including several dog and cat breeds, are
polymorphic for Neu5Gc expression. While overall tissue
expression is thought to be low, expression on blood cells in
these animals can be high (47, 48). Polymorphisms involving
Neu5Gc on the ganglioside GD3 exist in felids and are called
AB blood groups in domestic cats (not related to primate ABO
blood groups), where cats lacking Neu5Gc-GD3 have circulating
antibodies specific for Neu5Gc (47). Dog breeds also differ in
their expression of Neu5Gc on red blood cell glycolipids (48).
Due to the recessive nature of loss of function mutations, their
increase in frequency within a population must be mediated by
selection on homozygous carriers, who have fitness advantages
conferring higher survival and/or reproductive success. For
example, selection for polymorphisms involving a loss-of-
function mutation could be based on the accompanying ablation
of the glycan used as a receptor by pathogens (49–52).
Examples of Neu5Gc specific pathogens abound including
the protozoan malaria parasite P. reichenowi (53), the swine
pathogen E. coli K99 (54) and the macaque monkey virus
SV40 (55).
In contrast a number of human-specific pathogens evolved
specificity for Neu5Ac, including the causative agent of
human malignant malaria P. falciparum,the toxins of cholera
agent V. cholerae (56) and typhoid fever agent S. typhi
(57), and most influenza A viruses (58). Loss-of-function
mutations, especially in polymorphic populations, could also
provide partial protection from enveloped viruses that bear
the antigenic glycan acquired from the cell membrane of the
previous, Neu5Gc positive host. The latter mechanism would
be analogous to such protection in alpha-Gal negative Old
World primates (59–61) and across ABO mismatched humans
(62–65). Such protective mechanisms are thus observed both,
between species and within species with existing (balanced)
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polymorphisms. Balanced polymorphisms are maintained by
frequency-dependent selection, i.e., selection favoring the rare
variants, thus preventing their extinction but also preventing
their fixation (see Figure 3) (66). Such dynamic co-evolutionary
processes between pathogens and their hosts are the inspiration
behind the terms evolutionary arms race and Red-Queen
effects (15, 67).
Fixation of the loss-of-function allele, on the other hand, could
happen either via directional selection or genetic drift, where
small founder populations consist mostly of homozygous carriers
of the loss-of-function mutation. First defined using plants in
1962 (68) and recently applied to primates by Galili (65), the idea
of “catastrophic selection” combines these ideas with very strong
selection. It is not clear how such “catastrophic selection” differs
from short episodes of strong selection, possibly accompanied by
demographic bottlenecks, which could also result in the fixation
of loss-of-function mutations. Alternatively, selective pressure
for Cmah loss-of-function could occur through reproductive
conflict as discussed below.
Female Immune-Mediated Selection
Against Paternal Neu5Gc
Mammalian sperm are highly sialylated as a mechanism to
enhance sperm survival and function along the perilous journey
through the female reproductive tract to the site of fertilization in
the oviduct (69–71). Mammals make anti-sperm antibodies when
directly exposed to sperm (72). Major human sperm antigens
include, highly sialylated GPI-anchored glycoproteins such as
CD52 (73, 74), which in males that have a functional CMAH
FIGURE 3 | Schematic of the interplay of natural and sexual selection acting on cell-surface sialic acids. (A) Natural selection by pathogens recognizing and exploiting
Neu5Gc (blue diamond) as a receptor on host target cells can select for mutant CMAH(−) alleles that abolish expression of Neu5Gc in homozygote individuals and
prevent infection. Such homozygous null individuals have only Neu5Ac on their cells (red diamonds) and at higher frequencies would be targeted by other pathogens
adapted or adapting to the host glycan change (magenta). This equilibrium would result in maintenance of glycan polymorphism by balancing selection. (B)
Anti-Neu5Gc antibody-expressing CMAH(−/−) females, immunized by dietary consumption of Neu5Gc rich food (red meat) or by sperm antigens containing Neu5Gc,
favor loss-of-function alleles on sperm due to reproductive incompatibility with CMAH(−/+) or CMAH(+/+) males expressing Neu5Gc on their sperm. Once the
frequency of the CMAH(−) allele reaches a certain level, this process can drive the fixation of the CMAH(−) allele in a population via directional selection. Figure
modified from Ghaderi et al. (8).
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allele, carry Neu5Gc (75). Theoretically, immunization of females
homozygous for the loss-of-function allele of Cmah could occur
via insemination by males that have Neu5Gc-bearing sperm.
Indeed, we have shown experimentally, using Cmah(−/−) mice
immunized against Neu5Gc, that their immune response against
Neu5Gc bearing sperm severely reduces female fertility (8). In
a further study, we demonstrated that Neu5Gc bearing sperm,
both, sperm from either wild type mice or from Cmah(−/−) mice
exposed to seminal fluid from wildtype mice containing Neu5Gc-
rich CD52, are both targeted by antibodies and are increasingly
phagocytosed by female uterine immune cells (75). These insights
have potential relevance for human fertility where Neu5Gc or
anti-Neu5Gc antibodies in the reproductive tract are common
among infertility patients, but not healthy controls (29).
In addition to blocking fertilization, it is possible that anti-
Neu5Gc immunity from a primedCMAH(−/−)mother (29) could
also negatively affect a CMAH(+/−)embryo or fetus in a manner
similar to hemolytic diseases of the newborn caused by ABO
glycan mismatches.
Reproductive xenosialitis could thus be a plausible mechanism
mediating directional selection, leading to the fixation of the
loss-of-function allele in the population, irrespective of the
mechanism(s) involved for the initial selection favoring the
mutation (see Figure 4).
FIGURE 4 | Exogenous (dietary) Neu5Gc and anti-Neu5Gc antibody as contributing factors to unexplained human infertility. The combination of incorporated dietary
xenoglycan Neu5Gc (even in trace amounts) from red meat and milk products including cow milk-based infant formula and anti-Neu5Gc antibodies in males or
females (A) could have deleterious consequences on human fertility via a number of potentially additive mechanisms which include: (B) coating of sperm by male
and/or female anti-Neu5Gc antibodies, interference with sperm function, including passage through cervical mucins and/or other restrictive parts of the female
reproductive tract such as the utero-tubal junction, (C) increased sperm death via female cellular and humoral immunity, where most sperm are killed by female
immunity, (D) interference with sperm capacitation when sperm membranes get dynamically reconfigured, (E) interference with sperm penetration of vestment,
interference with sperm-egg interactions, (F) interference with endometrial decidualization and receptivity resulting in reduced success of implantation. Figure modified
from Ma et al. (75) with permission.
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CONCLUSIONS AND PERSPECTIVES
It is interesting that watershed events, such as the loss of Neu5Gc
from the glycocalyx of human cells have occurred numerous
times in many mammalian and other vertebrate species. These
cases of convergent evolution represent precious opportunities
for increased understanding of evolutionary processes. In some
respects, Neu5Gc is an ideal self-molecule as it is “private” to
vertebrates and, based on current data, has yet to be successfully
mimicked by microbes. Against the background of this benefit,
the loss of Neu5Gc appears paradoxical andmay implicate strong
selective regimes, either catastrophically caused by pathogens,
or under directional sexual selection via female immunity to
paternal xenoglycans. Massive genetic drift, or combinations of
milder selection and founder events, can also not be excluded.
More information on species expected to encounter Neu5Gc
in their diets, i.e., mustelids, pinnipeds, and humans, is needed
to begin answering several outstanding questions in the field:
For instance, what are the potential protective functions of
anti-Neu5Gc antibodies in species that lack this sialic acid,
especially as regards ongoing protection from cross-species
infections by enveloped viruses bearing Neu5Gc on their
viral envelopes? Or on the flip-side, what are the potential
liabilities of anti-Neu5Gc antibodies due to autoimmunity
against incorporated dietary Neu5Gc? Evolutionary events such
as the ones discussed here exemplify how glycans, rather than
representing the end result of different evolutionary histories
and contingencies, can become an evolutionary force of their
own and constrain future evolution of entire lineages including
subsequent compensatory evolution of glycan binding immune
receptors (15, 76).
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